Physical biology in cancer. 3. The role of cell glycocalyx in vascular transport of circulating tumor cells

American Journal of Physiology - Cell Physiology

Volumn 306, Issue 2, 2014, Pages

  Mitchell, Michael J ^a   King, Michael R ^a  

^a Cornell University   (United States)

Author keywords

Adhesion; Drug delivery; Metastasis; Microvasculature

Indexed keywords

DOCETAXEL; DOXORUBICIN; HYALURONIDASE; LIGAND; NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL STRUCTURE; CELL SURFACE; CELL TRANSPORT; CIRCULATING TUMOR CELL; DRUG TARGETING; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GLYCOCALYX; HUMAN; IN VITRO STUDY; METASTASIS; MICROVASCULATURE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ADHESION; DRUG DELIVERY; METASTASIS; MICROVASCULATURE;

ANIMALS; BIOLOGICAL TRANSPORT; ENDOTHELIUM, VASCULAR; GLYCOCALYX; HUMANS; NEOPLASTIC CELLS, CIRCULATING; PHYSICOCHEMICAL PHENOMENA;

EID: 84892567267     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00285.2013     Document Type: Article

References (142)

1. Adamson RH, Lenz JF, Zhang X, Adamson GN, Weinbaum S, Curry FE. Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol 557: 889-907, 2004.
2. Arisaka T, Mitsumata M, Kawasumi M, Tohjima T, Hirose S, Yoshida Y. Effects of shear stress on glycosaminoglycan synthesis in vascular endothelial cells. Ann NY Acad Sci 748: 543-554, 1995.
3. Ashkenazi A. Targeting death and decoy receptors of the tumournecrosis factor superfamily. Nat Rev Cancer 2: 420-430, 2002.
4. 1,3-Fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc Natl Acad Sci USA 106: 19491-19496, 2009.
5. Biancone L, Araki M, Araki K, Vassalli P, Stamenkovic I. Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med 183: 581-587, 1996.
6. Boucher Y, Jain RK. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 52: 5110-5114, 1992.
7. Bouma J, Beijnen JH, Bult A, Underberg WJ. Anthracycline antitumour agents. Pharm Weekbl Sci 8: 109-133, 1986.
8. Brekken C, de Lange Davies C. Hyaluronidase reduces the interstitial fluid pressure in solid tumours in a non-linear concentration-dependent manner. Cancer Lett 131: 65-70, 1998.
9. Brodt P, Fallavollita L, Bresalier RS, Meterissian S, Norton CR, Wolitzky BA. Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 71: 612-619, 1997.
10. Bruehl RE, Springer TA, Bainton DF. Quantitation of L-selectin distribution on human leukocyte microvilli by immunogold labeling and electron microscopy. J Histochem Cytochem 44: 835-844, 1996.
11. Burdick MM, Chu JT, Godar S, Sackstein R. HCELL is the major Eand L-selectin ligand expressed on LS174T colon carcinoma cells. J Biol Chem 281: 13899-13905, 2006.
12. Cao TM, Mitchell MJ, Liesveld J, King MR. Stem cell enrichment with selectin receptors: mimicking the pH environment of trauma. Sensors 13: 12516-12526, 2013.
13. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 331: 1559-1564, 2011.
14. Chambers AF, MacDonald IC, Schmidt EE, Koop S, Morris VL, Khokha R, Groom AC. Steps in tumor metastasis: new concepts from intravital microscopy. Cancer Metastasis Rev 14: 279-301, 1995.
15. Cheung LS, Raman PS, Balzer EM, Wirtz D, Konstantopoulos K. Biophysics of selectin-ligand interactions in inflammation and cancer. Phys Biol 8: 015013, 2011.
16. Constantinescu AA, Vink H, Spaan J. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol 23: 1541-1547, 2003.
17. Constantinescu AA, Vink H, Spaan JAE. Elevated capillary tube hematocrit reflects degradation of endothelial cell glycocalyx by oxidized LDL. Am J Physiol Heart Circ Physiol 280: H1051-H1057, 2001.
18. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392, 2002.
19. Coussens LM, Werb Z. Inflammation and cancer. Nature 420: 860-867, 2002.
20. Damiano ER, Long DS, El-Khatib FH. On the motion of a sphere in a Stokes flow parallel to a Brinkman half-space. J Fluid Mech 500: 75-101, 2004.
21. Damiano ER, Long DS, Smith ML. Estimation of viscosity profiles using velocimetry data from parallel flows of linearly viscous fluids: application to microvascular haemodynamics. J Fluid Mech 512: 1-19, 2004.
22. Desjardins C, Duling BR. Heparinase treatment suggests a role for the endothelial cell glycocalyx in regulation of capillary hematocrit. Am J Physiol Heart Circ Physiol 258: H647-H654, 1990.
23. Dimitroff CJ, Lechpammer M, Long-Woodward D, Kutok J. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res 64: 5261-5269, 2004.
24. Duda DG, Duyverman AM, Kohno M, Snuderl M, Steller EJ, Fukumura D, Jain RK. Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci USA 107: 21677-21682, 2010.
25. Eikenes L, Tufto I, Schnell EA, Bjorkoy A, de Lange Davies C. Effect of collagenase and hyaluronidase on free and anomalous diffusion in multicellular spheroids and xenografts. Anticancer Res 30: 359-368, 2010.
26. Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, Furukawa M, Sato H. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 278: 40764-40770, 2003.
27. Erikson A, Tufto I, Bjønnum AB, Bruland ØS, de Lange Davies C. The impact of enzymatic degradation on the uptake of differently sized therapeutic molecules. Anticancer Res 28: 3557-3566, 2008.
28. Fidler I. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat Rev Cancer 3: 1-6, 2003.
29. Fitzgerald ML, Wang Z, Park PW, Murphy G, Bernfield M. Shedding of syndecan-1 and-4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol 148: 811-824, 2000.
30. Fukumura D, Jain RK. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem 101: 937-949, 2007.
31. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503, 1994.
32. Giavazzi R, Foppolo M, Dossi R, Remuzzi A. Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest 92: 3038-3044, 1993.
33. Gout S, Tremblay P, Huot J. Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin Exp Metastasis 25: 335-344, 2008.
34. Götte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66: 10233-10237, 2006.
35. 34a. Grimm J, Keller R, deGroot PG. Laminar flow induces cell polarity and leads to rearrangement of proteoglycan metabolism in endothelial cells. Thromb Haemost 60: 437-441, 1988.
36. Grivennikov S, Greten F, Karin M. Immunity, inflammation, cancer. Cell 140: 883-899, 2010.
37. Gronski TJ, Martin RL, Kobayashi DK, Walsh BC, Holman MC, Huber M, Van Wart HE, Shapiro SD. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem 272: 12189-12194, 1997.
38. Guck J, Schinkinger S, Lincoln B, Wottawah F, Ebert S, Romeyke M, Lenz D, Erickson HM, Ananthakrishnan R, Mitchell D, Käs J, Ulvick S, Bilby C. Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophys J 88: 3689-3698, 2005.
39. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24, 1991.
40. Hamerman D, Todaro GJ, Green H. The production of hyaluronate by spontaneously established cell lines and viral transformed lines of fibroblastic origin. Biochim Biophys Acta 101: 343-351, 1965.
41. Henry CB, Duling BR. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol Heart Circ Physiol 277: H508-H514, 1999.
42. Henry CB, Duling BR. TNF-α increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 279: H2815-H2823, 2000.
43. Hofmann-Kiefer KF, Kemming GI, Chappell D, Flondor M, Kisch-Wedel H, Hauser A, Pallivathukal S, Conzen P, Rehm M. Serum heparan sulfate levels are elevated in endotoxemia. Eur J Med Res 14: 526-531, 2009.
44. Hopwood JJ, Dorfman A. Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40. J Biol Chem 252: 4777-4785, 1977.
45. Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Priest LJ, Greystoke A, Zhou C, Morris K, Ward T, Blackhall FH, Dive C. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 30: 525-532, 2012.
46. Hu X, Weinbaum S. A new view of Starling's hypothesis at the microstructural level. Microvasc Res 58: 281-304, 1999.
47. Hughes B, Hollers J, Crockett-Torabi E, Smith CW. Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion. J Clin Invest 90: 1687-1696, 1992.
48. Huxley VH, Curry FE. Differential actions of albumin and plasma on capillary solute permeability. Am J Physiol Heart Circ Physiol 260: H1645-H1654, 1991.
49. Itano N, Kimata K. Altered hyaluronan biosynthesis in cancer progression. Semin Cancer Biol 18: 268-274, 2008.
50. Itano N, Sawai T, Miyaishi O, Kimata K. Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res 59: 2499-2504, 1999.
51. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, McDonald JA, Kimata K. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274: 25085-25092, 1999.
52. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 71: 481-539, 1991.
53. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 48: 2641-2658, 1988.
54. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR, Strom SC. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6: 564-567, 2000.
55. Kalluri R, Weinberg R. The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420, 2009.
56. Keller MW, Damon DN, Duling BR. Determination of capillary tube hematocrit during arteriolar microperfusion. Am J Physiol Heart Circ Physiol 266: H2229-H2238, 1994.
57. King MR. Rolling in the deep: therapeutic targeting of circulating tumor cells. Front Oncol 2: 184, 2012.
58. Klingbeil P, Natrajan R, Everitt G, Vatcheva R, Marchio C, Palacios J, Buerger R, Reis-Filho JS, Isacke CM. CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification. Breast Cancer Res Treat 120: 95-109, 2010.
59. Klitzman B, Duling BR. Microvascular hematocrit and red cell flow in resting and contracting striated muscle. Am J Physiol Heart Circ Physiol 237: H481-H490, 1979.
60. Koo A, Dewey CF, Garcia-Cardena G. Hemodynamic shear stress characteristic of atherosclerosis-resistant regions promotes glycocalyx formation in cultured endothelial cells. Am J Physiol Cell Physiol 304: C137-C146, 2013.
61. Kosaki R, Watanabe K, Yamaguchi Y. Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorageindependent growth and tumorigenicity. Cancer Res 59: 1141-1145, 1999.
62. Kuo JS, Zhao Y, Schiro PG, Ng L, Lim DS, Shelby JP, Chiu DT. Deformability considerations in filtration of biological cells. Lab Chip 10: 837-842, 2010.
63. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65: 859-873, 1991.
64. Lawrence MB, Springer TA. Neutrophils roll on E-selectin. J Immunol 151: 6339-6346, 1993.
65. Lee D, Schultz JB, Knauf PA, King MR. Mechanical shedding of L-selectin from the neutrophil surface during rolling on sialyl Lewis X under flow. J Biol Chem 282: 4812-4820, 2007.
66. Leonard JG, Hale AH, Roll DE, Conrad HE, Weber MJ. Turnover of cellular carbohydrates in normal and Rous sarcoma virus-transformed cells. Cancer Res 38: 185-188, 1978.
67. Li J, King MR. Adhesion receptors as therapeutic targets for circulating tumor cells. Front Oncol 2: 1-9, 2012.
68. Li Y, Heldin P. Hyaluronan production increases the malignant properties of mesothelioma cells. Br J Cancer 85: 600-607, 2001.
69. Li Z, Li L, Zielke R, Cheng L, Xiao R, Crow MT, Stetler-Stevenson WG, Froehlich J, Lakatta EG. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 148: 121, 1996.
70. Lipowsky HH, Lescanic A. The effect of doxycycline on shedding of the glycocalyx due to reactive oxygen species. Microvasc Res. In press.
71. Lipowsky HH, Sah R, Lescanic A. Relative roles of doxycycline and cation chelation in endothelial glycan shedding and adhesion of leukocytes. Am J Physiol Heart Circ Physiol 300: H415-H422, 2011.
72. Lipowsky HH. The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases. Ann Biomed Eng 40: 840-848, 2012.
73. Liu N, Gao F, Han Z, Xu X, Underhill CB, Zhang L. Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Res 61: 5207-5214, 2001.
74. Madlener M, Parks WC, Werner S. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 242: 201-210, 1998.
75. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276: 75-81, 1997.
76. Matsumoto S, Imaeda Y, Umemoto S, Kobayashi K, Suzuki H, Okamoto T. Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer 86: 161-167, 2002.
77. Méhes G, Witt A, Kubista E, Ambros PF. Circulating breast cancer cells are frequently apoptotic. Am J Pathol 159: 17-20, 2001.
78. Michel CC. Starling: the formulation of his hypothesis of microvascular fluid exchange and its significance after 100 years. Exp Physiol 82: 1-30, 1997.
79. Mitchell MJ, Castellanos CA, King MR. Nanostructured surfaces to target and kill circulating tumor cells while repelling leukocytes. J Nanomaterials 2012: 1-10, 2012.
80. Mitchell MJ, Chen CS, Ponmudi V, Hughes AD, King MR. E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells. J Control Release 160: 609-617, 2012.
81. Mitchell MJ, King MR. Shear-induced resistance to neutrophil activation via the formyl peptide receptor. Biophys J 102: 1804-1814, 2012.
82. Mitchell MJ, King MR. Fluid shear stress sensitizes cancer cells to receptor-mediated apoptosis via trimeric death receptors. New J Physics 15: 015008, 2013.
83. Mitchell MJ, King MR. Computational and experimental models of cancer cell response to fluid shear stress. Front Oncol 3: 1-11, 2013.
84. Mitsiades N, Yu W, Poulaki V, Tsokos M, Stamenkovic I. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res 61: 577-581, 2001.
85. Monzavi-Karbassi B, Stanley JS, Hennings L, Jousheghany F, Artaud C, Shaaf S, Kieber-Emmons T. Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer 120: 1179-1191, 2007.
86. Mulivor AW, Lipowsky HH. Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol 283: H1282-H1291, 2002.
87. Mulivor AW, Lipowsky HH. Inflammation-and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol 286: H1672-H1680, 2004.
88. Nagano O, Okazaki S, Saya H. Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene 32: 5191-5198, 2013.
89. Oohira A, Wight TN, Bornstein P. Sulfated proteoglycans synthesized by vascular endothelial cells in culture. J Biol Chem 258: 2014-2021, 1983.
90. Osheroff N, Corbett AH, Robinson MJ. Mechanism of action of topoisomerase II-targeted antineoplastic drugs. Adv Pharmacol 29: 105-126, 1994.
91. Pang Z, Tarbell JM. In vitro study of Starling's hypothesis in a cultured monolayer of bovine aortic endothelial cells. J Vasc Res 40: 351-358, 2003.
92. Paszek MJ, DuFort CC, Rubashkin MG, Davidson MW, Thorn KS, Liphardt JT, Weaver VM. Scanning angle interference microscopy reveals cell dynamics at the nanoscale. Nat Methods 9: 825-827, 2012.
93. Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253: 180-204, 2007.
94. Pályi-Krekk Z, Barok M, Isola J, Tammi M, Szöllosi J, Nagy P. Hyaluronan-induced masking of ErbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancer. Eur J Cancer 43: 2423-2433, 2007.
95. Pályi-Krekk Z, Barok M, Kovács T, Saya H, Nagano O, Szöllosi J, Nagy P. EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44. Cancer Lett 263: 231-242, 2008.
96. Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflügers Arch 440: 653-666, 2000.
97. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104: 973-978, 2007.
98. Rana K, Liesveld JL, King MR. Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin. Biotechnol Bioeng 102: 1692-1702, 2009.
99. Rana K, Reinhart-King CA, King MR. Inducing apoptosis in rolling cancer cells: a combined therapy with aspirin and immobilized TRAIL and E-selectin. Mol Pharm 9: 2219-2227, 2012.
100. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Reichart B, Peter K, Becker BF. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 116: 1896-1906, 2007.
101. Reis CA, Osorio H, Silva L, Gomes C, David L. Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol 63: 322-329, 2010.
102. Reitsma S, Slaaf DW, Vink H, Zandvoort MA, Oude Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflügers Arch 454: 345-359, 2007.
103. Rilla K, Tiihonen R, Kultti A, Tammi M, Tammi R. Pericellular hyaluronan coat visualized in live cells with a fluorescent probe is scaffolded by plasma membrane protrusions. J Histochem Cytochem 56: 901-910, 2008.
104. Robert P, Nicolas A, Aranda-Espinoza S, Bongrand P, Limozin L. Minimal encounter time and separation determine ligand-receptor binding in cell adhesion. Biophys J 100: 2642-2651, 2011.
105. Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest 99: 2062-2070, 1997.
106. Rostgaard J, Qvortrup K. Electron microscopic demonstrations of filamentous molecular sieve plugs in capillary fenestrae. Microvasc Res 53: 1-13, 1997.
107. Sabri S, Soler M, Foa C, Pierres A, Benoliel A, Bongrand P. Glycocalyx modulation is a physiological means of regulating cell adhesion. J Cell Sci 113: 1589-1600, 2000.
108. Sarelius IH, Duling BR. Direct measurement of microvessel hematocrit, red cell flux, velocity, and transit time. Am J Physiol Heart Circ Physiol 243: H1018-H1026, 1982.
109. Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zöller M. Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177: 443-455, 1993.
110. Sironen RK, Tammi M, Tammi R, Auvinen PK, Anttila M, Kosma VM. Hyaluronan in human malignancies. Exp Cell Res 317: 383-391, 2011.
111. Soler M, Desplat-Jego S, Vacher B, Ponsonnet L, Fraterno M, Bongrand P, Martin JM, Foa C. Adhesion-related glycocalyx study: quantitative approach with imaging-spectrum in the energy filtering transmission electron microscope (EFTEM). FEBS Lett 429: 89-94, 1998.
112. Soler M, Merant C, Servant C, Fraterno M, Allasia C, Lissitzky JC, Bongrand P, Foa C. Leukosialin (CD43) behavior during adhesion of human monocytic THP-1 cells to red blood cells. J Leukoc Biol 61: 609-618, 1997.
113. Springer TA. Adhesion receptors of the immune system. Nature 346: 425-434, 1990.
114. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314, 1994.
115. Squire JM, Chew M, Nneji G, Neal C, Barry J, Michel C. Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering? J Struct Biol 136: 239-255, 2001.
116. Swartz MA, Lund AW. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer 12: 210-219, 2012.
117. Tan SJ, Yobas L, Lee GY, Ong CN, Lim CT. Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices 11: 883-892, 2009.
118. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160: 673-680, 2002.
119. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
120. Thompson CB, Shepard HM, O'Connor PM, Kadhim S, Jiang P, Osgood RJ, Bookbinder LH, Li X, Sugarman BJ, Connor RJ, Nadjsombati S, Frost GI. Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models. Mol Cancer Ther 9: 3052-3064, 2010.
121. Toole BP, Slomiany MG. Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin Cancer Biol 18: 244-250, 2008.
122. Toole BP, Wight TN, Tammi MI. Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 277: 4593-4596, 2002.
123. Tözeren A, Kleinman HK, Grant DS, Morales D, Mercurio A, Byers S. E-selectin-mediated dynamic interactions of breast and colon cancer cells with endothelial cell monolayers. Int J Cancer 60: 426-431, 1995.
124. Turitto VT. Blood viscosity, mass transport, thrombogenesis. Prog Hemost Thromb 6: 139-177, 1982.
125. van den Berg BM, Vink H, Spaan JA. The endothelial glycocalyx protects against myocardial edema. Circ Res 92: 592-594, 2003.
126. Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res 79: 581-589, 1996.
127. Vitte J, Benoliel AM, Pierres A, Bongrand P. Regulation of cell adhesion. Clin Hemorheol Microcirc 33: 167-188, 2005.
128. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, Lacour B, Bréchot C, Paterlini-Brechot P. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 156: 57-63, 2000.
129. Weigelt B, Peterse JL, van't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 5: 591-602, 2005.
130. Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 9: 121-167, 2007.
131. Weinbaum S, Zhang X, Han Y, Vink H, Cowin SC. Mechanotransduction and flow across the endothelial glycocalyx. Proc Natl Acad Sci USA 100: 7988-7995, 2003.
132. Whatcott CJ, Han H, Posner RG, Hostetter G, Hoff Von DD. Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look. Cancer Discovery 1: 291-296, 2011.
133. Wong SY, Hynes RO. Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5: 812-817, 2006.
134. Yang C, Cao M, Liu H, He Y, Xu J, Du Y, Liu Y, Wang W, Cui L, Hu J, Gao F. The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem 287: 43094-43107, 2012.
135. Yang C, Liu Y, He Y, Du Y, Wang W, Shi X, Gao F. The use of HA oligosaccharide-loaded nanoparticles to breach the endogenous hyaluronan glycocalyx for breast cancer therapy. Biomaterials 34: 6829-6838, 2013.
136. Young RC, Ozols RF, Myers CE. The anthracycline antineoplastic drugs. N Engl J Med 305: 139-153, 1981.
137. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson MC, Sequist LV, Brachtel E, Sgroi D, Baselga J, Ramaswamy S, Toner M, Haber DA, Maheswaran S. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339: 580-584, 2013.
138. Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 192: 373-382, 2011.
139. Yu WH, Woessner JF. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 275: 4183-4191, 2000.
140. Zeng Y, Waters M, Andrews A, Honarmandi P, Ebong E, Rizzo V, Tarbell JM. Fluid shear stress induces the clustering of heparan sulfate via mobility of glypican-1 in lipid rafts. Am J Physiol Heart Circ Physiol 305: H811-H820, 2013.
141. Zhao Y, Chien S, Weinbaum S. Dynamic contact forces on leukocyte microvilli and their penetration of the endothelial glycocalyx. Biophys J 80: 1124-1140, 2001.
142. Zheng S, Lin H, Liu JQ, Balic M, Datar R, Cote RJ, Tai YC. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A 1162: 154-161, 2007.